CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to improve cancer treatment by investigating the mechanisms behind tumor heterogeneity and its impact on therapy response. By targeting specific pathways, it seeks to enhance the effectiveness of radiotherapy while minimizing side effects on normal tissues.
Cancer is a devastating disease affecting 1 in 3 people in their lifetime.
The incidence is rising because of our aging population and causes a huge economic impact on our society because of hospitalization and lost productivity.
Radiotherapy alone or in combination with surgery and/or chemotherapy is used in ~50% of all patients and uses ionizing radiation to induce DNA breaks that are lethal to cells.
While significant progress has been made, radiotherapy is often limited because of side-effec…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
New Zealand, Auckland
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
